Head-to-head · Cost-Efficiency Index
Teladoc Health vs LovelyMeds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Teladoc Health
Patients whose employer or insurance plan already includes Teladoc Health's GLP-1 program -- not a fit for cash-pay shoppers comparing prices.
Visit Teladoc HealthLovelyMeds
Shoppers who want a wide product selection (compounded + branded) and don't mind price-shopping through an intake quiz.
Visit LovelyMedsThe verdict
Teladoc Health takes it, leading the Cost-Efficiency Index 41 to 39. Teladoc Health is the large, publicly traded telehealth company; its GLP-1 program is only accessible through an employer- or insurance-sponsored plan. LovelyMeds still earns a C — Shoppers who want a wide product selection (compounded + branded) and don't mind price-shopping through an intake quiz.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Teladoc Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Teladoc Health | LovelyMeds |
|---|---|---|
| Cost-Efficiency Index | 41/100 | 39/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #522 | #528 |
Teladoc Health
41/100Where the value is
- Backed by a large, publicly traded, well-established telehealth infrastructure
- GLP-1 program integrated into a broader virtual weight-management and primary-care offering
- Self-pay fallback is mentioned as theoretically available if insurance doesn't cover the drug
The tradeoffs
- No direct-to-consumer cash-pay pricing published anywhere -- access requires an employer/insurance sponsor
- Not usable by an individual cash-pay shopper simply comparing GLP-1 prices online
LovelyMeds
39/100Where the value is
- Very broad catalog: both compounded and branded semaglutide/tirzepatide options
- Wide state coverage (excludes only 4 states: KS, LA, MS, NM)
- Multiple delivery formats offered (injection, oral drops, troche)
The tradeoffs
- No pricing disclosed anywhere on the public site
- No named medical director or specific compounding pharmacy
Regulatory note: the FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025. We still list and link to LovelyMeds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.